Adhera Therapeutics, Inc. — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b484d69c-ffaa-4e09-a974-85c79585eb3a/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-1.6M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-010160 |
| FY 2021 | $-674.0k | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-010064 |
| FY 2020 | $-2.0M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-008190 |
| FY 2019 | $-11.3M | 2019-01-01 – 2019-12-31 | evidence 0000737207-20-000006 |
| FY 2018 | $-15.8M | 2018-01-01 – 2018-12-31 | evidence 0000737207-20-000006 |
| FY 2017 | $-6.1M | 2017-01-01 – 2017-12-31 | evidence 0001493152-18-005372 |
| FY 2016 | $-757.7k | 2016-01-01 – 2016-12-31 | evidence 0001493152-17-003272 |
| FY 2015 | $-1.1M | 2015-01-01 – 2015-12-31 | evidence 0001493152-17-003272 |
| FY 2014 | $-3.5M | 2014-01-01 – 2014-12-31 | evidence 0001571049-15-001227 |
| FY 2013 | $-365.0k | 2013-01-01 – 2013-12-31 | evidence 0001571049-14-003630 |
| FY 2012 | $-7.9M | 2012-01-01 – 2012-12-31 | evidence 0001571049-14-003110 |
| FY 2011 | $-35.0M | 2011-01-01 – 2011-12-31 | evidence 0001144204-12-055514 |
| FY 2010 | $-29.5M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-055514 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).